-
Argus Upgrades McDonald's To Buy, Sees It Outperforming Peers As Turnaround Continues
Wednesday, January 27, 2016 - 9:49am | 315Read More...McDonald's Corporation (NYSE: MCD) shares have gained 7 percent since October 27. Argus’ John Staszak upgraded the rating for the company from Hold to Buy, with a price target of $140. The company is poised to perform better than peers, given good progress in its turnaround plan...
-
Argus Reiterates $93 Target On Eli Lilly, Highlights 'Strong Late-Stage Pipeline'
Friday, January 15, 2016 - 11:41am | 224Read More...The share price of Eli Lilly and Co (NYSE: LLY) has appreciated 16.59 percent over the past year, from $69.74 on January 15, 2015. Argus’ Jacob Kilstein has reiterated a Buy rating and $93 price target on the company. Kilstein believes that the company has a solid late-stage...
-
Argus Hikes Nokia To Buy, Says Alcatel-Lucent Creates 'Synergies'
Friday, January 15, 2016 - 10:35am | 227Read More...Nokia Corporation (ADR) (NYSE: NOK) shares were volatile in 2015, and are up 5 percent since January 4 this year. Argus’ Jim Kelleher upgraded the rating for the company from Hold to Buy, with a price target of $12. The company is poised to benefit from the synergies resulting from...
-
Argus Downgrades Alcoa, Sees Weak Near-Term Earnings
Thursday, January 14, 2016 - 10:37am | 330Read More...The share price of Alcoa Inc (NYSE: AA) has declined 55.8 percent over the past one year, touching a low of $7.13 on January 13. Argus’ David Coleman has downgraded the rating on the company from Buy to Hold. Coleman believes that although the stock offers value, earnings...
-
Becton Dickinson Has More Room To Grow; Argus Reiterates Buy Rating
Thursday, January 7, 2016 - 10:42am | 382Read More...Argus Research issued a company note on Becton Dickinson and Co (NYSE: BDX) following the visible benefits of the acquisition of CareFusion, which has helped drive better than expected revenue growth and improved profitability. Argus reiterated Becton Dickinson's Buy rating and $167 price target....
-
Argus Hikes PPL Corp Outlook, Says Business Focus Leads To Higher Multiple
Thursday, December 31, 2015 - 10:17am | 243Read More...Shares of PPL Corp (NYSE: PPL) appreciated 16.53 percent over the past six months, although they dipped almost to their 52 week low on September 9, at $29.41. Argus' Jim Kelleher has maintained a Buy rating on the company, while raising the price target from $35 to $40. The company...
-
Argus: Honeywell Has Upside, Will Make More Strategic Acquisitions
Tuesday, December 29, 2015 - 11:58am | 307Read More...Honeywell International Inc. (NYSE: HON) shares have appreciated 13.91 percent over the past three months, rising to $104.96 on December 23. Argus’ John Eade has maintained a Buy rating and price target of $118 on the company. Honeywell’s stock has appreciated over 9 percent...
-
Best Buy Harmed By Difficult Environment; Argus Reiterates Hold
Tuesday, December 29, 2015 - 10:59am | 396Read More...Best Buy Co Inc (NYSE: BBY) shares have declined 14.04 percent over the past three months, falling to $29.04 on December 18. Argus’ Christopher Graja recently reiterated a Hold rating on the company. Graja believes the company is facing a difficult industry environment and that the below...
-
Zoetis Is The Only Publicly-Traded Pure-Play Animal Health, Vaccine Company
Monday, December 28, 2015 - 10:32am | 311Read More...Zoetis Inc (NYSE: ZTS) shares have appreciated 11.85 percent year-to-date, trading at their 52-week high of $55.38 on June 25. Argus’ John Eade has maintained a Buy rating on the company, with a price target of $57. While the company has raised its EPS guidance and dividend, Eade...
-
Argus Reaffirms Buy On Nike; Raises Estimates And Price Target
Monday, December 28, 2015 - 9:10am | 289Read More...Shares of Nike Inc (NYSE: NKE) have soared 31.41 percent year to date, rising close to their 52 week high on November 27 at $67.165. Argus’ John Staszak has maintained a Buy rating on the company, while raising the price target from $75 to $77. The company has continued to gain...
-
Argus Says Celgene's Patent Settlement Boosts Its Revenue Outlook
Thursday, December 24, 2015 - 9:45am | 314Read More...Celgene Corporation (NASDAQ: CELG) shares have been volatile in 2015, and have gained 9 percent year-to-date. Argus’ David Toung maintained a Buy rating for the company, with a price target of $155. The settlement of the Revlimid patent litigation provided increased visibility into...
-
Micron's DRAM Price Weakness Hinders Guidance
Thursday, December 24, 2015 - 9:20am | 317Read More...Micron Technology, Inc. (NASDAQ: MU) shares are down 58 percent year-to-date. Argus’ Jim Kelleher maintained a Buy rating for the company, while reducing the price target from $26 to $22. Micron reported mixed results for F1Q and announced disappointing guidance, refleting continued...
-
Argus Upgrades Sun Life Financial To Buy
Wednesday, December 23, 2015 - 10:02am | 262Read More...The share price of Sun Life Financial Inc (NYSE: SLF) has declined 13.87 percent year-to-date, from a high of 36.06 on December 31, 2014. Argus' Stephen Biggar has upgraded the rating on the company from Hold to Buy, with a price target of $37. The upgrade in the rating is based on...
-
Argus Lifts Price Target On GE From $34 To $36
Wednesday, December 23, 2015 - 9:15am | 303Read More...General Electric Company (NYSE: GE) shares have climbed 21 percent in the last three months, from a low of $24.31 on September 28. Argus’ John Eade maintained a Buy rating on the company, while raising the price target from $34 to $36. The divestment of GE Capital is essentially...
-
Nabors Industries Shares Decline After Argus Analyst Says Recovery Could Take Longer
Wednesday, December 16, 2015 - 10:31am | 259Read More...Shares of Nabors Industries Ltd. (NYSE: NBR) have declined 37.47 percent year-to-date, almost touching their 52-week low on Monday at $8.63. Argus’ Bill Selesky has downgraded the rating on the company from Buy to Hold. Selesky believes the company would take longer to recover that...
